文献速递疝与腹壁外科急腹症与外科感染

污染性腹壁疝单期修补中生物补片与合成补片的补片相关结局:随机对照试验5至10年分析

Mesh-related Outcomes of Biologic Versus Synthetic Mesh for Single-stage Repair of Contaminated Ventral Hernias: A 5 to 10-year Analysis of a Randomized Controlled Trial.
PubMed 文献 · Ann Surg · 2025-08-12

本研究对多中心随机对照试验(NCT02451176)中253例污染性腹壁疝单期修补患者进行至少5年随访,比较生物补片与合成补片的长期安全性和耐久性。合成补片组中线疝复发风险显著降低(HR=0.46,95%CI 0.25-0.86,P=0.015),5至10年总体复发率17.8%(生物组23.6% vs 合成组11.8%),绝对风险降低11.8%(95%CI 2.1-21.4)。术后2年以上两组均无新发补片感染或补片取出,合成补片未增加补片相关并发症。

要点

  • 合成补片组5至10年中线疝复发风险显著低于生物补片组(HR=0.46)。
  • 复发率绝对风险降低11.8%,优势主要集中在术后2年内。
  • 术后2年以上两组均无新发补片感染或补片取出。

核心结论

  • 在清洁-污染和污染性腹壁疝修补中,与生物补片相比,合成补片提供更优的长期复发结局且不增加补片相关并发症。

研究设计与样本

  • 多中心随机对照试验(NCT02451176)的至少5年随访分析,纳入253例患者。
  • 随访率达到80.2%(n=203),中位随访5.4年(四分位距2.1-6.8),平均5.5年(标准差2.7)。

主要发现

  • 合成补片与中线疝复发风险显著降低相关(风险比=0.46,95%CI 0.25-0.86,P=0.015)。
  • 5至10年总体中线复发率为17.8%:生物补片组23.6%,合成补片组11.8%。
  • 合成补片的绝对风险降低为11.8%(95%CI 2.1-21.4)。
  • 复发优势主要见于术后前2年,2年后两组复发率无显著差异。
  • 术后2年以上两组均无新发补片感染或补片取出,3例(1.2%)因持续伤口相关问题需干预。

临床怎么用

  • 对于清洁-污染和污染性腹壁疝单期修补,可优先考虑合成补片以降低长期复发风险。
  • 合成补片未增加远期补片感染或取出风险,支持其在此类污染条件下的长期安全性。

局限性

  • 随访率80.2%,存在失访偏倚可能。
  • 复发优势主要集中于术后2年内,2年后两组无显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the 5 to 10-year safety and durability outcomes of biologic versus synthetic mesh in contaminated ventral hernia repair. BACKGROUND: Recent randomized controlled trials have demonstrated the safety and efficacy of synthetic mesh in clean-contaminated and contaminated ventral hernia repairs, but follow-up has typically been limited to 2 years. Concerns persist regarding long-term outcomes of synthetic mesh beyond this initial period. METHODS: A minimum 5-year follow-up analysis was conducted on 253 patients from our multicenter randomized controlled trial (NCT02451176). The primary outcome was cumulative long-term midline hernia recurrence risk. Secondary outcomes were long-term complications including mesh-related infection, excision, and reoperation. RESULTS: Follow-up was achieved in 80.2% (n=203) of patients with a median follow-up of 5.4 years (interquartile range: 2.1-6.8) and mean of 5.5 years (SD: 2.7). Synthetic mesh was associated with a significant reduction in midline hernia recurrence risk (hazard ratio=0.46, 95% CI: 0.25-0.86, P =0.015). The 5 to 10-year overall midline recurrence rate was 17.8%: 23.6% in the biologic group and 11.8% in the synthetic group, corresponding to an absolute risk reduction of 11.8% (95% CI: 2.1-21.4) with synthetic mesh. This advantage was primarily observed within the first 2 years with no significant difference in recurrence rates beyond 2 years. No new mesh infections or excisions occurred in either group beyond 2 years postoperatively. Three patients (1.2%) required intervention for ongoing wound-related issues. CONCLUSIONS: Synthetic mesh provides superior long-term recurrence outcomes without increased mesh-related complications in clean-contaminated and contaminated repairs when compared with biologic mesh.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Remulla D, Carvalho A, Birrell AM, et al. Mesh-related Outcomes of Biologic Versus Synthetic Mesh for Single-stage Repair of Contaminated Ventral Hernias: A 5 to 10-year Analysis of a Randomized Controlled Trial. Ann Surg. 2025. PMID: 40792628. doi:10.1097/SLA.0000000000006906

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。